At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
KURE KraneShares MSCI All China Health Care Index ETF
Pre-Mkt 08-04 09:00:25 EDT
17.08
-0.20
-1.13%
盘前17.46
+0.38+2.20%
07:35 EDT
High17.15Low17.01Vol17.62K
Open17.03D1 Closing17.28Amplitude0.84%
Mkt Cap98.25MTradable Cap98.25MTotal Shares5.75M
T/O300.93KT/O Rate0.31%Tradable Shares5.75M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

CSPC Pharma Unit, Alphamab Oncology's Breast Cancer Drug Application Granted Priority Review in China
MT Newswires Live  ·  19:34
CSPC Pharma Unit, Alphamab Oncology's Breast Cancer Drug Application Granted Priority Review in China
CSPC Says NMPA Accepts NDA for Anbenitamab, Albumin-Bound Docetaxel Neoadjuvant Breast Cancer Combo Under Priority Review
Reuters  ·  18:12
CSPC Says NMPA Accepts NDA for Anbenitamab, Albumin-Bound Docetaxel Neoadjuvant Breast Cancer Combo Under Priority Review
Alphamab Oncology Says NMPA Accepts NDA for Anbenitamab (kn026)
Reuters  ·  18:04
Alphamab Oncology Says NMPA Accepts NDA for Anbenitamab (kn026)
Wuxi Biologics (Cayman) Stock Climbs 4.3% in Hong Kong
Dow Jones  ·  16:31
Wuxi Biologics (Cayman) Stock Climbs 4.3% in Hong Kong
CRO Stocks Surge: Multiple Overseas MNCs and CXO Firms Report Strong Interim Results, Raise Full-Year Guidance
Stock News  ·  11:08
CRO Stocks Surge: Multiple Overseas MNCs and CXO Firms Report Strong Interim Results, Raise Full-Year Guidance
Hong Kong Market Opens Higher as Pharma and Tech Stocks Lead Gains
Stock News  ·  09:46
Hong Kong Market Opens Higher as Pharma and Tech Stocks Lead Gains
CSPC Pharma Begins Phase Ib/II Trial of Colorectal Cancer Drug Candidate
MT Newswires Live  ·  08-03 20:56
CSPC Pharma Begins Phase Ib/II Trial of Colorectal Cancer Drug Candidate
CSPC Pharmaceutical - Initiates Phase Ib/Ii Trial of Sys 6090 Injection for Colorectal Cancer in China
THOMSON REUTERS  ·  08-03 19:33
CSPC Pharmaceutical - Initiates Phase Ib/Ii Trial of Sys 6090 Injection for Colorectal Cancer in China
Akeso (SEHK:9926) Dosed Its First AK138D1 Patient, Is The 47% Undervalued View Too Bullish?
Simply Wall St.  ·  08-03 19:20
Akeso (SEHK:9926) Dosed Its First AK138D1 Patient, Is The 47% Undervalued View Too Bullish?
CSPC Pharmaceutical Group Stock Falls 1.3% in Hong Kong
Dow Jones  ·  08-03 16:33
CSPC Pharmaceutical Group Stock Falls 1.3% in Hong Kong
BeOne Medicines AG Expected to Post Earnings of 15 Cents a Share - Earnings Preview
Reuters  ·  08-03 16:02
BeOne Medicines AG Expected to Post Earnings of 15 Cents a Share - Earnings Preview
CSPC Pharma Wins China Trial Approval for RSV Vaccine
MT Newswires Live  ·  08-03 09:42
CSPC Pharma Wins China Trial Approval for RSV Vaccine
CSPC Pharmaceutical Group's SYS6041 Combination Therapy Phase II Trial for Recurrent Ovarian Cancer Has Officially Launched at the First Center in China
Stock News  ·  07-31
CSPC Pharmaceutical Group's SYS6041 Combination Therapy Phase II Trial for Recurrent Ovarian Cancer Has Officially Launched at the First Center in China
CSPC Pharma Says China Clears Clinical Trial for RSV Vaccine Candidate SYS 6057
Reuters  ·  07-31
CSPC Pharma Says China Clears Clinical Trial for RSV Vaccine Candidate SYS 6057
CSPC Pharmaceutical - Pharma's Recombinant Rsv Vaccine (Sys6057) Obtains Clinical Trial Approval in China
THOMSON REUTERS  ·  07-31
CSPC Pharmaceutical - Pharma's Recombinant Rsv Vaccine (Sys6057) Obtains Clinical Trial Approval in China
Medtide Names Ding Lijun as CFO
Reuters  ·  07-31
Medtide Names Ding Lijun as CFO
Wuxi Biologics (Cayman) Stock Rallies 2.5% in Hong Kong
Dow Jones  ·  07-31
Wuxi Biologics (Cayman) Stock Rallies 2.5% in Hong Kong
Hong Kong Stock Movers: Several Innovative Drug Stocks Rally in Afternoon Trading, GENSCRIPT BIO Surges Nearly 8%, REMEGEN Gains Over 4%
Stock News  ·  07-31
Hong Kong Stock Movers: Several Innovative Drug Stocks Rally in Afternoon Trading, GENSCRIPT BIO Surges Nearly 8%, REMEGEN Gains Over 4%
National Bulk Drug Procurement Round 12 to Begin Bidding in Shanghai
Deep News  ·  07-31
National Bulk Drug Procurement Round 12 to Begin Bidding in Shanghai
China's domestic innovative drugs set for overseas revenue breakthrough as policy support strengthens
Stock News  ·  07-31
China's domestic innovative drugs set for overseas revenue breakthrough as policy support strengthens

Introduction

Company Name.
KraneShares MSCI All China Health Care Index ETF
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.
Issue price:
--